Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Osteoclast progenitors reside in the peroxisome proliferator-activated receptor γ-expressing bone marrow cell population.

Wei W, Zeve D, Wang X, Du Y, Tang W, Dechow PC, Graff JM, Wan Y.

Mol Cell Biol. 2011 Dec;31(23):4692-705. doi: 10.1128/MCB.05979-11. Epub 2011 Sep 26.

2.

Biphasic and dosage-dependent regulation of osteoclastogenesis by β-catenin.

Wei W, Zeve D, Suh JM, Wang X, Du Y, Zerwekh JE, Dechow PC, Graff JM, Wan Y.

Mol Cell Biol. 2011 Dec;31(23):4706-19. doi: 10.1128/MCB.05980-11. Epub 2011 Aug 29.

3.

TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.

Kanazawa K, Kudo A.

J Bone Miner Res. 2005 May;20(5):840-7. Epub 2004 Dec 20.

4.

Erk1 positively regulates osteoclast differentiation and bone resorptive activity.

He Y, Staser K, Rhodes SD, Liu Y, Wu X, Park SJ, Yuan J, Yang X, Li X, Jiang L, Chen S, Yang FC.

PLoS One. 2011;6(9):e24780. doi: 10.1371/journal.pone.0024780. Epub 2011 Sep 22.

5.

Cell adhesion signaling regulates RANK expression in osteoclast precursors.

Mochizuki A, Takami M, Miyamoto Y, Nakamaki T, Tomoyasu S, Kadono Y, Tanaka S, Inoue T, Kamijo R.

PLoS One. 2012;7(11):e48795. doi: 10.1371/journal.pone.0048795. Epub 2012 Nov 6.

6.

Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.

Kim HJ, Yoon KA, Yoon HJ, Hong JM, Lee MJ, Lee IK, Kim SY.

J Leukoc Biol. 2013 Jul;94(1):99-107. doi: 10.1189/jlb.1112601. Epub 2013 May 8.

7.

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.

Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T.

J Exp Med. 2000 Jan 17;191(2):275-86.

8.

Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.

Ikeda F, Nishimura R, Matsubara T, Tanaka S, Inoue J, Reddy SV, Hata K, Yamashita K, Hiraga T, Watanabe T, Kukita T, Yoshioka K, Rao A, Yoneda T.

J Clin Invest. 2004 Aug;114(4):475-84.

9.

PPAR-gamma regulates osteoclastogenesis in mice.

Wan Y, Chong LW, Evans RM.

Nat Med. 2007 Dec;13(12):1496-503. Epub 2007 Dec 2.

PMID:
18059282
12.

Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells.

Yamada T, Yamazaki H, Yamane T, Yoshino M, Okuyama H, Tsuneto M, Kurino T, Hayashi S, Sakano S.

Blood. 2003 Mar 15;101(6):2227-34. Epub 2002 Oct 31.

13.

c-fos antisense DNA inhibits proliferation of osteoclast progenitors in osteoclast development but not macrophage differentiation in vitro.

Udagawa N, Chan J, Wada S, Findlay DM, Hamilton JA, Martin TJ.

Bone. 1996 Jun;18(6):511-6.

PMID:
8805990
14.

Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.

Kim MH, Ryu SY, Choi JS, Min YK, Kim SH.

J Cell Physiol. 2009 Dec;221(3):618-28. doi: 10.1002/jcp.21892.

PMID:
19653230
16.

Myeloid Elf-1-like factor stimulates adipogenic differentiation through the induction of peroxisome proliferator-activated receptor γ expression in bone marrow.

Baek K, Cho JY, Hwang HR, Kwon A, Lee HL, Park HJ, Qadir AS, Ryoo HM, Woo KM, Baek JH.

J Cell Physiol. 2012 Nov;227(11):3603-12. doi: 10.1002/jcp.24064.

PMID:
22307523
17.

The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.

Yang J, Park OJ, Lee YJ, Jung HM, Woo KM, Choi Y.

Eur J Immunol. 2008 Jun;38(6):1598-609. doi: 10.1002/eji.200737650.

18.

Identification of multiple osteoclast precursor populations in murine bone marrow.

Jacquin C, Gran DE, Lee SK, Lorenzo JA, Aguila HL.

J Bone Miner Res. 2006 Jan;21(1):67-77. Epub 2005 Oct 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk